HEALTHSOUTH (NYSE: HLS ) is expected to report Q4 earnings on Feb. 18. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict HEALTHSOUTH's revenues will increase 5.3% and EPS will shrink -25.6%.
The average estimate for revenue is $545.5 million. On the bottom line, the average EPS estimate is $0.32.
Last quarter, HEALTHSOUTH recorded revenue of $537.0 million. GAAP reported sales were 7.9% higher than the prior-year quarter's $497.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.37. GAAP EPS of $0.44 for Q3 were 19% lower than the prior-year quarter's $0.54 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 46.7%, 90 basis points better than the prior-year quarter. Operating margin was 19.0%, 90 basis points better than the prior-year quarter. Net margin was 8.8%, 270 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $2.15 billion. The average EPS estimate is $1.56.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on HEALTHSOUTH is outperform, with an average price target of $26.83.
Is HEALTHSOUTH the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.